MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, MARAVAI LIFESCIENCES HOLDINGS, INC. reported revenue of $185.74M, down 28.3% from the prior year. The company ran a net loss, with a net margin of -70.4% and a gross margin of 18.3%. It held $770.58M in total assets against $397.87M in total liabilities.
Key ratios (FY2025)
18.3%
Gross margin
-115.9%
Operating margin
-70.4%
Net margin
-35.1%
Return on equity
-28.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $185.74M | $259.19M | $288.94M | $883.00M | $799.24M | $284.10M | $143.14M |
| Cost of Revenue | $151.75M | $150.88M | $148.74M | $168.96M | $140.56M | $79.65M | $66.85M |
| Gross Profit | $33.99M | $108.31M | $140.20M | — | — | — | — |
| Operating Income | -$215.27M | -$235.62M | -$31.65M | $574.22M | $554.64M | $119.90M | $23.99M |
| Net Income | -$130.77M | -$144.85M | -$119.03M | $220.21M | $182.04M | $88.97M | -$4.47M |
| EPS (Diluted) | $-0.90 | $-1.05 | $-0.90 | $1.67 | $1.56 | $2.36 | $-0.03 |
| Total Assets | $770.58M | $1.01B | $1.49B | $2.28B | $1.92B | $1.27B | — |
| Total Liabilities | $397.87M | $431.04M | $697.57M | $1.38B | $1.37B | $1.12B | — |
| Shareholders' Equity | $372.71M | $577.21M | $789.88M | $905.24M | $545.36M | $154.75M | $144.63M |
| Cash & Equivalents | $216.89M | $322.40M | $574.96M | $632.14M | — | — | — |
| Operating Cash Flow | -$57.57M | $7.46M | $126.22M | $535.98M | $368.57M | $152.19M | $24.11M |
| Capital Expenditures | $13.15M | $29.66M | $65.55M | $17.09M | $14.85M | $25.41M | $17.15M |
| Shares Outstanding | 144.36M | 137.91M | 131.92M | 255.32M | 257.80M | 28.91M | 253.92M |